HR 4464 Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Summary
This bill amends the Congressional Budget Act to allow budget committees to request special budget scoring analysis for legislation that would reduce future government spending through preventive health care. Upon such a request, the Director of the Office of Management and Budget must determine whether proposed legislation would result in net reductions in budget costs in future years through preventive health measures. If cost reductions are found, the Director must provide a description and estimate of those reductions and the basis for the conclusions. Such estimates may be prepared for extended budget periods of up to 20 years into the future, beyond the normal projection timeframes. The resulting estimates serve only as supplementary information and cannot be used to determine compliance with budgetary enforcement rules.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
19 cosponsors
- Rep. Balderson, Troy [R-OH-12] (R-OH)
- Rep. Buchanan, Vern [R-FL-16] (R-FL)
- Rep. Carter, Earl L. "Buddy" [R-GA-1] (R-GA)
- Rep. Conaway, Herbert C. [D-NJ-3] (D-NJ)
- Rep. DeGette, Diana [D-CO-1] (D-CO)
- Rep. DelBene, Suzan K. [D-WA-1] (D-WA)
- Rep. Foster, Bill [D-IL-11] (D-IL)
- Rep. Kiley, Kevin [R-CA-3] (R-CA)
- Rep. Kim, Young [R-CA-40] (R-CA)
- Rep. Miller, Carol D. [R-WV-1] (R-WV)
- Rep. Moore, Blake D. [R-UT-1] (R-UT)
- Rep. Murphy, Gregory F. [R-NC-3] (R-NC)
- Rep. Onder, Robert F. [R-MO-3] (R-MO)
- Rep. Peters, Scott H. [D-CA-50] (D-CA)
- Rep. Schrier, Kim [D-WA-8] (D-WA)
- Rep. Smucker, Lloyd [R-PA-11] (R-PA)
- Rep. Tran, Derek [D-CA-45] (D-CA)
- Rep. Vindman, Eugene Simon [D-VA-7] (D-VA)
- Rep. Yakym, Rudy [R-IN-2] (R-IN)
Money behind the sponsor
Top reported contributors to Jay Obernolte’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $69,760
- GOOGLE $17,500
- ROUTE 66 SHOOTING $13,200
- APPLE VALLEY COMMUNICATIONS $13,200
- CHANDI GROUP USA $13,200
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Jay Obernolte → · Outside spending →
Actions (2)
- Jul 16, 2025 Referred to the House Committee on the Budget. · house
- Jul 16, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
July 16, 2025
Mr. Obernolte (for himself, Ms. DeGette, Mr. Peters, and Mr. Carter of Georgia) introduced the following bill; which was referred to the Committee on the Budget
A BILL
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Preventive Health Savings Act”.
SEC. 2. SCORING OF PREVENTIVE HEALTH SAVINGS.
Section 202 of the Congressional Budget and Impoundment Control Act of 1974 (2 U.S.C. 602) is amended by adding at the end the following:
“(h) Scoring of Preventive Health Savings.—
“(1) Determination by the director.—Upon a request by the chairman and ranking minority member of the Committee on the Budget of the Senate and chairman and ranking minority member of the committee of primary jurisdiction of the Senate or by the chairman and ranking minority member of the Committee on the Budget of the House of Representatives and the chairman and ranking minority member of the committee of primary jurisdiction of the House of Representatives, the Director shall determine if proposed legislation would result in net reductions in budget outlays in budgetary outyears through the use of preventive health care.
“(2) Projections.—If the Director determines that proposed legislation would result in net reductions in budget outlays as described in paragraph (1), the Director—
“(A) shall include, in any projection prepared by the Director on such proposed legislation, a description and estimate of the reductions in budget outlays in the budgetary outyears and a description of the basis for such conclusions; and
“(B) may prepare a budget projection that includes some or all of the budgetary outyears, notwithstanding the time periods for projections described in subsection (e) and sections 308, 402, and 424.
“(3) Limitation.—Any estimate provided by the Director pursuant to paragraph (1) shall be used as a supplementary estimate and may not be used to determine compliance with the Congressional Budget Act of 1974 or any other budgetary enforcement controls.
“(4) Definitions.—As used in this subsection—
“(A) the term ‘budgetary outyears’ means the 2 consecutive 10-year periods beginning with the first fiscal year that is 10 years after the current fiscal year; and
“(B) the term ‘preventive health care’ means an action that focuses on the health of the public, individuals, and defined populations in order to protect, promote, and maintain health and wellness and prevent disease, disability, and premature death, including through the promotion and use of effective, innovative health care interventions that are demonstrated by credible and publicly available evidence from epidemiological projection models, clinical trials, observational studies in humans, longitudinal studies, and meta-analysis.”. <all>
Comments